HBW Advisory Services LLC reduced its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 24.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 6,281 shares of the pharmacy operator’s stock after selling 2,012 shares during the period. HBW Advisory Services LLC’s holdings in CVS Health were worth $395,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Ables Iannone Moore & Associates Inc. purchased a new position in shares of CVS Health in the 4th quarter worth about $32,000. First Community Trust NA boosted its stake in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after buying an additional 302 shares in the last quarter. Creekmur Asset Management LLC purchased a new position in shares of CVS Health during the fourth quarter worth approximately $34,000. Steph & Co. lifted its holdings in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after acquiring an additional 288 shares during the last quarter. Finally, ORG Partners LLC boosted its stake in shares of CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.
CVS Health Trading Up 2.7 %
CVS stock traded up $1.67 during midday trading on Friday, reaching $64.59. 16,313,877 shares of the company traded hands, compared to its average volume of 11,032,696. The firm has a market capitalization of $81.08 billion, a price-to-earnings ratio of 11.35, a P/E/G ratio of 0.81 and a beta of 0.54. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. The business has a 50 day moving average of $58.60 and a 200-day moving average of $61.58. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25.
CVS Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.12%. CVS Health’s dividend payout ratio is 46.75%.
Analyst Ratings Changes
A number of equities research analysts recently commented on the stock. Evercore ISI lowered their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft dropped their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. Barclays dropped their price objective on CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. Wells Fargo & Company raised their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Ten research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $73.40.
View Our Latest Research Report on CVS Health
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- MarketBeat Week in Review – 9/30 – 10/4
- ETF Screener: Uses and Step-by-Step Guide
- Top Streaming Companies: Who’s Winning the Battle?
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.